NCT03728842Active, not recruiting
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma
Blood Drawing for Study of Peripheral Blood T-lymphocytes and Other Parameters in Patients With Metastatic Melanoma and Renal Cell Cancer With Spontaneous Regression
Source: ClinicalTrials.gov · Last updated 27 Oct 2025
Brief summary (registry, in English)
The purpose of this study is to collect blood and clinical data from patients with metastatic melanoma and renal cell cancer who have experienced spontaneous regression for studies of immune response and other factors that may influence these occurrences.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 19 (actual)
- First submitted
- 5 Oct 2018
- Start date
- 4 Jan 2004
- Primary completion date
- 1 Mar 2027
- Lead sponsor
- Indiana University
- Diseases
- Kidney cancer, Melanoma
- NCT number
- NCT03728842
What you commit to
- Study type: Observational
- Participants enrolled: 19
- From 4 Jan 2004 to the primary completion date, 1 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent disease or condition that would make the patient inappropriate for study participation or any serious medical or psychiatric disorder that would interfere with the subject's safety
Other illness
- Dementia, altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent
Who the study is looking for
- ≥ 18 years old at the time of informed consent
- Ability to provide written informed consent and HIPAA authorization
- Patients must have metastatic melanoma or renal cell cancer with spontaneous regression.
- Willingness to undergo phlebotomy for research blood samples
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Indiana University Simon Cancer Center Coordinator of this site? Confirm its status | Indianapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.